TP
CVS icon

Tranquility Partners’s CVS Health CVS Stock Holding History

Tranquility Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
4,771
-23
-0.5% -$2.05K 0.17% 140
2026
Q1 		$344K Hold
4,794
– – 0.13% 163
2025
Q4 		$380K Sell
4,794
-143
-3% -$11.3K 0.14% 155
2025
Q3 		$372K Buy
+4,937
New +$338K 0.13% 166
2024
Q4 		– Sell
-5,055
Closed -$318K – 211
2024
Q3 		$318K Sell
5,055
-243
-5% -$14.2K 0.12% 169
2024
Q2 		$313K Sell
5,298
-289
-5% -$18.1K 0.12% 165
2024
Q1 		$446K Sell
5,587
-375
-6% -$28.6K 0.17% 136
2023
Q4 		$471K Sell
5,962
-1,172
-16% -$83.4K 0.2% 120
2023
Q3 		$498K Sell
7,134
-300
-4% -$21.3K 0.21% 118
2023
Q2 		$514K Sell
7,434
-1,570
-17% -$112K 0.22% 118
2023
Q1 		$669K Buy
9,004
+1,537
+21% +$129K 0.32% 86
2022
Q4 		$696K Sell
7,467
-400
-5% -$38.6K 0.35% 74
2022
Q3 		$750K Buy
7,867
+100
+1% +$9.9K 0.42% 68
2022
Q2 		$720K Buy
7,767
+420
+6% +$41K 0.37% 76
2022
Q1 		$744K Buy
7,347
+395
+6% +$41.5K 0.35% 78
2021
Q4 		$717K Sell
6,952
-150
-2% -$13.9K 0.33% 83
2021
Q3 		$603K Buy
7,102
+1,850
+35% +$155K 0.31% 90
2021
Q2 		$438K Buy
5,252
+250
+5% +$20.5K 0.25% 111
2021
Q1 		$376K Hold
5,002
– – 0.23% 121
2020
Q4 		$342K Hold
5,002
– – 0.24% 109
2020
Q3 		$292K Sell
5,002
-1,395
-22% -$86.8K 0.25% 109
2020
Q2 		$416K Buy
6,397
+560
+10% +$35.3K 0.39% 78
2020
Q1 		$346K Buy
+5,837
New +$390K 0.4% 73

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Tranquility Partners's CVS Position: Q2 2026 in Review

Tranquility Partners reduced its CVS Health (CVS) stake by 0.48% in Q2 2026, selling an estimated $2.05K and leaving 4,771 shares worth $494K. The position accounts for 0.17% of the portfolio, ranked #140.

Tranquility Partners first reported a position in CVS in Q1 2020 and has held it in 23 quarters since. The position peaked at $750K in Q3 2022. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Tranquility Partners held 4,771 shares of CVS Health worth $494K as of Q2 2026.
  • Tranquility Partners sold 23 CVS Health shares in Q2 2026, an estimated $2.05K.
  • CVS Health made up 0.17% of Tranquility Partners's portfolio in Q2 2026, its #140 holding.
  • Tranquility Partners first reported a position in CVS Health in Q1 2020 and has held it in 23 quarters since.
  • Tranquility Partners's CVS Health position peaked at $750K in Q3 2022.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tranquility Partners's 13F filing for Q2 2026, filed 23 Jul 2026.